Amylin Corporation
Records under this name other than patents Amylin Corporation holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 10 of 10 · Back to Amylin Corporation
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 6,048,514 | Amylin activity assays Formerly held Term ended Term ended Apr 11, 2017 · USPTO record | Term ended | Term ended Apr 11, 2017 | USPTO record |
| US 5,234,906 | Hyperglycemic compositions Term ended Term ended no later than Aug 10, 2013 · Low confidence | Term ended | Term ended no later than Aug 10, 2013 | Low confidence |
| US 5,260,275 | Hypoglycemics Term ended Term ended no later than Nov 9, 2013 · Low confidence | Term ended | Term ended no later than Nov 9, 2013 | Low confidence |
| US 5,264,372 | Receptor-based screening methods for amylin agonists and antagonists Term ended Term ended no later than Nov 23, 2013 · Low confidence | Term ended | Term ended no later than Nov 23, 2013 | Low confidence |
| US 5,321,008 | Methods and compositions for treatment of diabetes mellitus, hypoglycemia, and other conditions Term ended Term ended no later than Jun 14, 2014 · Low confidence | Term ended | Term ended no later than Jun 14, 2014 | Low confidence |
| US 5,367,052 | Amylin peptides Term ended Term ended no later than Nov 22, 2014 · Low confidence | Term ended | Term ended no later than Nov 22, 2014 | Low confidence |
| US 5,580,953 | Amylin antagonist peptides and uses therefor Formerly held Term ended Term ended no later than Dec 3, 2016 · Low confidence | Term ended | Term ended no later than Dec 3, 2016 | Low confidence |
| US 5,686,411 | Amylin agonist peptides and uses therefor Formerly held Term ended Term ended no later than Nov 11, 2017 · Low confidence | Term ended | Term ended no later than Nov 11, 2017 | Low confidence |
| US 5,716,619 | Treatment of type 2 diabetes mellitus Formerly held Term ended Term ended no later than Feb 10, 2018 · Low confidence | Term ended | Term ended no later than Feb 10, 2018 | Low confidence |
| US 5,998,367 | Pramlintide pro H-amylin salts and compositions Formerly held Term ended Term ended no later than Dec 7, 2019 · Low confidence | Term ended | Term ended no later than Dec 7, 2019 | Low confidence |